Trial Profile
Safety and Efficacy of CD5024 0.3% Cream in Subjects With Atopic Dermatitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 May 2023
Price :
$35
*
At a glance
- Drugs Ivermectin (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors Galderma
- 16 Aug 2017 New trial record